全文获取类型
收费全文 | 2208篇 |
免费 | 116篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 32篇 |
妇产科学 | 31篇 |
基础医学 | 212篇 |
口腔科学 | 27篇 |
临床医学 | 131篇 |
内科学 | 598篇 |
皮肤病学 | 105篇 |
神经病学 | 118篇 |
特种医学 | 199篇 |
外科学 | 410篇 |
综合类 | 6篇 |
预防医学 | 70篇 |
眼科学 | 17篇 |
药学 | 166篇 |
中国医学 | 3篇 |
肿瘤学 | 168篇 |
出版年
2023年 | 11篇 |
2021年 | 35篇 |
2020年 | 29篇 |
2019年 | 55篇 |
2018年 | 53篇 |
2017年 | 46篇 |
2016年 | 39篇 |
2015年 | 44篇 |
2014年 | 44篇 |
2013年 | 68篇 |
2012年 | 108篇 |
2011年 | 122篇 |
2010年 | 74篇 |
2009年 | 64篇 |
2008年 | 118篇 |
2007年 | 128篇 |
2006年 | 121篇 |
2005年 | 104篇 |
2004年 | 94篇 |
2003年 | 89篇 |
2002年 | 96篇 |
2001年 | 60篇 |
2000年 | 70篇 |
1999年 | 71篇 |
1998年 | 29篇 |
1997年 | 25篇 |
1996年 | 25篇 |
1995年 | 16篇 |
1994年 | 18篇 |
1993年 | 21篇 |
1992年 | 45篇 |
1991年 | 43篇 |
1990年 | 45篇 |
1989年 | 38篇 |
1988年 | 36篇 |
1987年 | 31篇 |
1986年 | 31篇 |
1985年 | 21篇 |
1984年 | 21篇 |
1983年 | 16篇 |
1981年 | 8篇 |
1979年 | 22篇 |
1978年 | 9篇 |
1977年 | 7篇 |
1976年 | 9篇 |
1974年 | 8篇 |
1972年 | 8篇 |
1971年 | 7篇 |
1969年 | 8篇 |
1968年 | 12篇 |
排序方式: 共有2333条查询结果,搜索用时 15 毫秒
1.
Takehiko Mori Souichi Shiratori Junji Suzumiya Mineo Kurokawa Motohiro Shindo Uchida Naoyuki Takenaka Katsuto Toshihiro Miyamoto Satoshi Morishige Makoto Hirokawa Takahiro Fukuda Yoshiko Atsuta Ritsuro Suzuki 《Hematological oncology》2020,38(3):266-271
Although allogeneic hematopoietic stem cell transplantation (HSCT) has been reported to provide prolonged remission of relapsed/refractory mycosis fungoides (MF) and Sézary syndrome (SS), its role has not been fully evaluated. Here, the outcomes of allogeneic HSCT for patients with MF/SS were retrospectively evaluated by using the registry database of the Japan Society for Hematopoietic Cell Transplantation. Forty-eight patients were evaluable and enrolled in the analysis. Median age was 45.5 years. Eighteen patients (38%) received myeloablative conditioning, and 33 (69%) received HSCT from an alternative donor. Disease status was complete or partial response in 25% of the patients and relapsed or refractory in the others. At the time of analysis, 18 patients were alive, with a median follow-up of 31.0 months (range, 3.8-31.1). Three-year overall survival (OS) and progression-free survival (PFS) were 30% (95%CI, 16-45%) and 19% (95%CI, 9-31%), respectively. Disease progression was not observed later than 17 months after transplantation. Both disease status and performance status at transplant significantly affected OS and PFS. Although our findings suggest that allogeneic HSCT provides long-term PFS in patients with MF/SS, the timing of transplantation should be decided carefully based on the disease status and the patient's condition in order to improve the outcome. 相似文献
2.
Yushi Katsuyama Norihisa Taira Tatsuya Tsuboi Masato Yoshioka Yuri Okano Hitoshi Masaki 《Experimental dermatology》2019,28(Z1):64-68
Skin sensitivity is a serious problem for many people, and it can be induced by various factors such as UV irradiation, physical and mental stresses, air pollution, dry air and so on. Skin dryness triggered by UV and dry air is one of the most important causes inducing the development of sensitive skin, and it has been reported that oxidative stress contributes to skin dryness. In this study, we investigated whether treatment with 3‐O‐laurylglyceryl ascorbate (VC‐3LG), which is an amphipathic ascorbic acid derivative, can suppress the development of sensitive skin. The results demonstrate that VC‐3LG restores the expression levels of interleukin‐1α, nerve growth factor and matrix metalloprotease‐9 in the dry skin models of reconstructed human epidermal equivalents (RHEEs) and in H2O2‐treated keratinocytes. In addition, VC‐3LG suppresses the dendrite elongation of nerve cells induced in RHEEs by dry skin conditions and by H2O2 treatment of keratinocytes. Therefore, we consider that treatment of the skin with VC‐3LG is an effective approach to improve the development of sensitive skin. 相似文献
3.
4.
Ibu Katayama Hidemasa Nakaminami Tetsuya Yamada Hideaki Ikoshi Norihisa Noguchi 《The Journal of dermatology》2020,47(7):714-719
An alternative approach, such as antivirulence therapy that modulates the production of bacterial toxins or virulence factors, is necessary to tackle the emergence of antimicrobial-resistant strains. Here, we investigated the potential antivirulence effects of seven Kampo medicines (Jumihaidokuto, Eppikajutsuto, Jizusoippo, Shomakakkonto, Sammotsuogonto, Hainosankyuto and Inchinkoto) against exfoliative toxin (ET)-positive Staphylococcus aureus, which is the major causative agent of impetigo. A growth inhibition assay showed that all of the selected Kampo medicines inhibited the growth of S. aureus at 1/5 (2.5 mg/mL) or less of the conventionally used concentrations. Among these, Jizusoippo and Inchinkoto (0.25–1 mg/mL) suppressed the production of ET without inhibiting the bacterial growth. Furthermore, Jizusoippo and Inchinkoto significantly suppressed the expression of ET genes in a concentration-dependent manner. Our findings strongly suggest, for the first time, that Kampo medicines, especially Jizusoippo and Inchinkoto, have the potential to serve as antivirulence agents against skin infections caused by S. aureus by suppressing the production of ET. 相似文献
5.
Masayo Yamamoto Motohiro Shindo Chihiro Sumi Sho Igarashi Takeshi Saito Nodoka Tsukada Yasumichi Toki Mayumi Hatayama Junki Inamura Kazuya Sato Yusuke Mizukami Yoshihiro Torimoto Toshikatsu Okumura 《Medicine》2021,100(16)
Introduction:Acquired hemophilia A (AHA) is a rare bleeding disorder caused by autoantibodies against factor VIII (FVIII). Hematological malignancies, especially lymphoid malignancies, are known to be underlying causes of AHA; however, thus far, there is no report of AHA associated with Epstein–Barr-virus-associated T/natural killer-cell lymphoproliferative disease (EBV-T/NK-LPD). Here, we present a case of AHA that developed during treatment for EBV-T/NK-LPD.History:A 69-year-old man visited our hospital because of general fatigue. Blood examination showed pancytopenia, and computed tomography revealed whole-body lymphadenopathy, but there were no findings indicating hematological malignancy from bone marrow aspiration and cervical lymph node biopsy. The level of EBV DNA in peripheral blood was extremely high, and he was diagnosed with EBV-T/NK-LPD. EBV-T/NK-LPD improved with prednisolone (PSL) administration. Seventeen months after starting treatment, the patient complained of back and right leg pain. At that time, he had been treated with low-dose PSL, and EBV-T/NK-LPD was well controlled. Imaging revealed hematoma of the right iliopsoas muscle. Prolonged activated partial thromboplastin time (APTT) was the only abnormal finding in a screening coagulation test. FVIII coagulant activity was below detection limit, and FVIII inhibitor level was increased. From these results, he was diagnosed with AHA.A higher dose of PSL was administered, and, after 1 month of treatment, FVIII activity gradually increased, and FVIII inhibitor level became undetectable. APTT also normalized, and complete remission was achieved and maintained for 13 months with low-dose PSL. During treatment, EBV-T/NK-LPD was well controlled.Conclusion:It is speculated that proliferating lymphocytes interfere with normal immune functions and that abnormal autoantibodies are produced from those lymphocytes in patients with LPD. Therefore, we speculate that EBV-infected and proliferating monoclonal NK cells might have modulated the immune system and produced autoantibodies against FVIII, thus causing AHA in this patient with EBV-T/NK-LPD. 相似文献
6.
Yosuke Tanaka Soichiro Sonoda Haruyoshi Yamaza Sara Murata Kento Nishida Yukari Kyumoto-Nakamura Norihisa Uehara Kazuaki Nonaka Toshio Kukita Takayoshi Yamaza 《Journal of endodontics》2019,45(5):591-598.e6
Introduction
Stem cells isolated from the root apical papilla of human teeth (stem cells from the apical papilla [SCAPs]) are capable of forming tooth root dentin and are a feasible source for bioengineered tooth root regeneration. In this study, we examined the effect of acetylsalicylic acid (ASA) on odontogenic differentiation of SCAPs in vitro and in vivo.Methods
SCAPs were cultured under odontogenic conditions supplemented with or without ASA. ASA-treated SCAPs were also subcutaneously transplanted into immunocompromised mice.Results
ASA accelerates in vitro and in vivo odontogenic differentiation of SCAPs associated with down-regulation of runt-related nuclear factor 2 and up-regulation of specificity protein 7, nuclear factor I C, and dentin phosphoprotein. ASA up-regulated the phosphorylation of AKT in the odontogenic SCAPs. Of interest, pretreatments with phosphoinositide 3-kinase inhibitor LY294402 and small interfering RNA for AKT promoted ASA-induced in vitro and in vivo odontogenic differentiation of SCAPs. LY294402 and small interfering RNA for AKT also suppressed the ASA-induced expression of runt-related nuclear factor 2 and enhanced ASA-induced expression of specificity protein 7, nuclear factor I C, and dentin phosphoprotein in SCAPs.Conclusions
These findings suggest that a combination of ASA treatment and suppressive regulation of the phosphoinositide 3-kinase–AKT signaling pathway is a novel approach for SCAP-based tooth root regeneration. 相似文献7.
Kimura Yuta Tsunedomi Ryouichi Yoshimura Kiyoshi Matsukuma Satoshi Shindo Yoshitaro Matsui Hiroto Tokumitsu Yukio Yoshida Shin Iida Michihisa Suzuki Nobuaki Takeda Shigeru Ioka Tatsuya Hazama Shoichi Nagano Hiroaki 《Annals of surgical oncology》2022,29(12):7423-7433
Annals of Surgical Oncology - Poor prognosis in liver cancer is due to its high frequency of intrahepatic metastasis. Cancer stem-like cells (CSLCs), which possess the properties of stemness, tumor... 相似文献
8.
9.
Hamamoto S Fukuda R Ishimura N Rumi MA Kazumori H Uchida Y Kadowaki Y Ishihara S Kinoshita Y 《The Journal of laboratory and clinical medicine》2003,141(1):58-66
The concentration of type I interferon receptor (IFN-Rc) in the liver is a crucial factor in determining the efficacy of interferon (IFN) therapy in patients with chronic hepatitis C. Retinoic acids (RAs) can enhance the expression of type I IFN-Rc expression. The aim of this study was to investigate whether RAs increase the anti-hepatitis C virus (HCV) effect of IFN through an increase in IFN-Rc. The hepatocellular carcinoma cell line HuH-7 was treated with 10(-7) mol/L all-trans RA (ATRA) and 9-cis RA (9-CRA). Expression of type I IFN-Rc was investigated at both the mRNA and protein levels with the use of real-time quantitative polymerase chain reaction and flow cytometry, respectively. We investigated the anti-HCV effect, using in vitro HCV transfection, by monitoring the level of HCV RNA in the culture medium. ATRA and 9-CRA enhanced the expression of type I IFN-Rc at both the mRNA and protein levels. After IFN-alpha treatment, the activity of 2,5'-oligoadenylate synthetase was enhanced by RAs, and this enhancement was abolished when blocking antibodies had previously been bound to the surface receptors. IFN treatment decreased the concentration of HCV RNA, and this effect was enhanced by treatment with RAs. Our findings suggest that RAs enhance the anti-HCV replication effect of IFN-alpha through up-regulation of type I IFN-Rc in HuH-7 cells. 相似文献